Presepsin Diagnostic Performance in Severe Burn Sepsis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

138 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study enrolls approximately 270 adult patients with severe burns covering at least 20% of total body surface area to evaluate how well the blood biomarker presepsin diagnoses sepsis early in this high-risk population. Sepsis-a life-threatening condition caused by an exaggerated immune response to infection-is particularly urgent to detect promptly in burn patients. Participants will undergo blood tests for presepsin at predefined time points, and these results will be compared to C-reactive protein (CRP), procalcitonin (PCT) levels, Sepsis-3 clinical criteria, and blood culture findings. The primary goal is to measure presepsin's sensitivity and specificity for sepsis detection, thereby determining its diagnostic accuracy. Findings from this study may enable faster sepsis treatment in severe burn patients and improve clinical outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

NCT02052895

SIRS Sepsis

COMPLETED

Relationship Between Neutrophil Function and Sepsis in Adults and Children With Severe Thermal Injuries

NCT04693442

Burns

UNKNOWN

Repository for Sepsis and Postresuscitation Samples

NCT01670383

Cardiac Arrest Sepsis

RECRUITING

Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction

NCT05060679

Sepsis Acute Kidney Injury Due to Sepsis Septic Shock +1 more

COMPLETED

Use of Presepsin in the Emergency Department

NCT06150092

Sepsis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Burns

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged ≥ 18 years admitted to Hangang Sacred Heart Hospital Burn ICU with total body surface area (TBSA) ≥ 20 %
* Clinical suspicion of sepsis prompting blood culture and biomarker sampling
* Ability to understand the study and provide written informed consent (or via legally authorized representative)

Exclusion Criteria

* Inability to undergo research blood draw due to emergent surgery or major trauma at sampling time
* Chronic immunosuppressive conditions (e.g., long-term high-dose steroids, organ transplant, congenital immunodeficiency)
* Pregnant women or those with significant psychiatric conditions precluding consent
* Any other medical or safety concerns deemed inappropriate by the investigator

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No